FTC Requires Parent Company of Bausch + Lomb to Divest Paragon
Date
Canadian pharmaceutical conglomerate Valeant Pharmaceuticals International, Inc., parent of Bausch + Lomb, has agreed to divest Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition...